6.7 DIC / Txfn Issues Flashcards
1
Q
Define the pathogenesis of DIC
A
- Precipitating event (sepsis, trauma, uterine injury) leads to cytokine activity and TNF/endotoxin release
- Tissue factor activated
- Increased thrombin activity
- Increased clotting activity -> ischemia, end organ damage
- Clots trap platelets, leading to larger clots
- Clotting inhibitors inactivated
- Clotting in micro and macro vasculature leads to consumption & depletion of clotting factors and platelets
- Increased fibrinolysis –> hemorrhage
- Excess thrombin leads to excess conversion of plasminogen to plasmin –> prolonged fibrinolysis
- Fibrin degradation/split products are anticoagulants
- Meanwhile, clotting factors and platelets exhausted
- Overstimulated fibrinolytic phase leads to excessive bleeding
- Hemorrhagic shock
- Increased vascular permeability exacerbated volume loss
- Increased clotting activity -> ischemia, end organ damage
2
Q
Your patient has DIC. How will you treat?
A
- Treat inciting event
- Abx for sepsis
- Volume resuscitation
- Hemostasis
- Replete clotting factors and platelets
- Check CBC, PT/INR, fibrinogen
- Give platelets, FFP, cryoprecipitate
- Consider heparin gtt for inhibitation of Factor Xa and thrombin -> interupt excessive thrombin production
3
Q
When transfusing your patient, remember the following:
- PRBCs can be transfused for patients with __________, ______________, _____________, and for symptomatic patients with acute or chronic ___________ or ___________________.
- 1 unit PRBC raises hgb ____ and hct ____
- Transfuse for hgb _____ unles evidence of ________________ or _______________ for which you should transfuse at hgb of ______.
A
- PRBCs can be transfused for patients with active hemorrhage, to improve tissue perfusion and oxygen delivery, and for symptomatic patients with acute or chronic anemia or bleeding disorders.
- 1 unit PRBC raises hgb 1g/dL and hct 3%
- Transfuse for hgb 7g/dL unles evidence of coronary artery ischemia or active bleeding for which you should transfuse at hgb of 8g/dL.
4
Q
Transfuse platelets if:
- Less than ________ in patients with multi-trauma, TBI, or spontaneous ICH. Can also consider this level for higher risk surgical procedures.
- Less than ________ in patients with active bleeding
- Less than ________ in patients planning invasive/surgical procedure.
- Less than ________ for outpatients, septic patients, or minor procedures.
- Less than ________ for stable patients.
- Regardless of platelet count for patients who are _______________________________.
A
Transfuse platelets if:
- Less than 100k in patients with multi-trauma, TBI, or spontaneous ICH. Can also consider this level for higher risk surgical procedures.
- Less than 50k in patients with active bleeding
- Less than 50k in patients planning invasive/surgical procedure.
- Less than 20k for outpatients, septic patients, or minor procedures otherwise stable.
- Less than 10k for stable patients.
- Regardless of platelet count for patients who are actively bleeding with use of platelet inhibitor medications.
5
Q
- FFP is a blood component that contains:
- Txfn of FFP should be considered for:
A
- FFP is a blood component that contains:
- Albumin
- Fibrinogen
- Factors II, VII, IX, X, and XI
- Txfn of FFP should be considered for:
- Massive transfusion
- Pts with INR > 1.6
- Emergency reversal of warfarin (and oral ACs, but less effective)
- Tx of DIC
- Replacement fluid for apheresis in patients with thrombotic microangiopathies
6
Q
Cryo
- 1u cryoprecipitate is pooled from ____ units of plasma
- Cryo contains:
- Should only be used in:
A
- 1u cryoprecipitate is pooled from 10 units of plasma
- Cryo contains
- vW Factor
- Factors VIII and XIII
- Fibrinogen by the bushel
- Should only be used in:
- Low fibrinogen states
- Hemorrhage
- DIC
- Low fibrinogen states
7
Q
What ratio of what products should your massive transfusion protocol contain
A
- 6 pRBCs : 1 plt (comes from 6u WB) : 6 FFP
- 1:1:1